The impact of FLIPI on outcome of frontline treatment with single-agent I-131 tositumomab for follicular lymphoma (FL)

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 4 de junio del 2006

Translation for this article does not exist

Blogs

Smoothies for All Occasions
by OncoLink Editorial Team
May 24, 2016